Table 3 
TREATMENT OF PATIENTS WITH METASTATIC MELANOMA 
USING TUMOR INFILTRATING LYMPHOCYTES 
Total 
PR + CR 
% PR + ' 
(number of 
patients) 
No previous IL-2 therapy 
39 
15 
38 % 
Previous IL-2 therapy 
11 
4 
36 % 
Total 
^ , % 
50 
19 
38 % 
Recombinant DNA Research, Volume 14 
[291] 
